Claris Ventures SGR announces the final closing of “Claris Biotech I” fund and
“Claris Biotech I – Parallel Fund” for a total amount of € 85M. The
capital raised will be mainly invested in new biotech companies based in
Italy developing drugs to treat diseases with high clinical need.The
final closing has been subscribed by the European Investment Fund
(EIF), with an investment of € 40M, supported by the European
Commission’s “InnovFin...